Centene Corp (CNC) stock
CNCNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 7/302% above fair value
$67.45−5.10 (-7.03%)
Close on Nov 18, 2026Market cap $33.39BP/E 23.1Yield –
Centene free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Centene's free cash flow for the twelve months ending Sep 30, 2026 was $3.94B, up 17.5% year over year. For fiscal 2025 it was $4.32B. Over ten years it grew 23.9% a year on average. The highest annual figure on record is $7.25B in fiscal 2023.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.32B | – |
| FY2024 | Dec 31, 2024 | -$490.00M | -106.8% |
| FY2023 | Dec 31, 2023 | $7.25B | +38.0% |
| FY2022 | Dec 31, 2022 | $5.26B | +59.5% |
| FY2021 | Dec 31, 2021 | $3.30B | -28.9% |
| FY2020 | Dec 31, 2020 | $4.63B | +515.4% |
| FY2019 | Dec 31, 2019 | $753.00M | +34.7% |
| FY2018 | Dec 31, 2018 | $559.00M | -47.6% |
| FY2017 | Dec 31, 2017 | $1.07B | -30.9% |
| FY2016 | Dec 31, 2016 | $1.55B | +204.1% |
| FY2015 | Dec 31, 2015 | $508.00M | -54.6% |
| FY2014 | Dec 31, 2014 | $1.12B | +256.7% |
| FY2013 | Dec 31, 2013 | $314.00M | +59.4% |
| FY2012 | Dec 31, 2012 | $197.00M | +4.8% |
| FY2011 | Dec 31, 2011 | $187.99M | +273.2% |
| FY2010 | Dec 31, 2010 | $50.38M | -77.6% |
| FY2009 | Dec 31, 2009 | $224.47M | +43.1% |
| FY2008 | Dec 31, 2008 | $156.82M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$3.86B | -437.4% |
| Q2 FY2026 | Jun 30, 2026 | $3.42B | +116.6% |
| Q1 FY2026 | Mar 31, 2026 | $4.17B | +203.0% |
| Q4 FY2025 | Dec 31, 2025 | $224.00M | – |
| Q3 FY2025 | Sep 30, 2025 | $1.15B | – |
| Q2 FY2025 | Jun 30, 2025 | $1.58B | -20.7% |
| Q1 FY2025 | Mar 31, 2025 | $1.38B | – |
| Q4 FY2024 | Dec 31, 2024 | -$741.00M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.13B | -227.8% |
| Q2 FY2024 | Jun 30, 2024 | $1.99B | -14.7% |
| Q1 FY2024 | Mar 31, 2024 | -$607.00M | -115.0% |
| Q4 FY2023 | Dec 31, 2023 | -$6.00M | – |
| Q3 FY2023 | Sep 30, 2023 | $885.00M | -71.3% |
| Q2 FY2023 | Jun 30, 2023 | $2.33B | -24.1% |
| Q1 FY2023 | Mar 31, 2023 | $4.04B | +344.9% |
| Q4 FY2022 | Dec 31, 2022 | -$1.81B | -523.7% |
| Q3 FY2022 | Sep 30, 2022 | $3.09B | +95.6% |
| Q2 FY2022 | Jun 30, 2022 | $3.07B | +114.1% |
| Q1 FY2022 | Mar 31, 2022 | $909.00M | – |
| Q4 FY2021 | Dec 31, 2021 | $427.00M | -84.6% |
| Q3 FY2021 | Sep 30, 2021 | $1.58B | – |
| Q2 FY2021 | Jun 30, 2021 | $1.44B | -58.8% |
| Q1 FY2021 | Mar 31, 2021 | -$144.00M | – |
| Q4 FY2020 | Dec 31, 2020 | $2.78B | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.20B | – |
| Q2 FY2020 | Jun 30, 2020 | $3.48B | +359.6% |
| Q1 FY2020 | Mar 31, 2020 | -$417.00M | -136.6% |
| Q4 FY2019 | Dec 31, 2019 | -$851.00M | – |
| Q3 FY2019 | Sep 30, 2019 | -$293.00M | -169.6% |
| Q2 FY2019 | Jun 30, 2019 | $757.00M | – |
| Q1 FY2019 | Mar 31, 2019 | $1.14B | -30.0% |
| Q4 FY2018 | Dec 31, 2018 | -$820.00M | -349.2% |
| Q3 FY2018 | Sep 30, 2018 | $421.00M | – |
| Q2 FY2018 | Jun 30, 2018 | -$670.00M | – |
| Q1 FY2018 | Mar 31, 2018 | $1.63B | +39.7% |
| Q4 FY2017 | Dec 31, 2017 | $329.00M | -78.0% |
| Q3 FY2017 | Sep 30, 2017 | -$23.00M | – |
| Q2 FY2017 | Jun 30, 2017 | -$404.00M | – |
| Q1 FY2017 | Mar 31, 2017 | $1.17B | – |
| Q4 FY2016 | Dec 31, 2016 | $1.50B | – |
See a number that looks wrong?